Skip to content
Screener

uniQure QURE Operating Income

Operating Income at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$13.29M-88.5%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-$43.49M-103%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$44.96M-95.4%
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
-$19.71M+3.5%
Candel Therapeutics, Inc. logo
Candel Therapeutics, Inc.CADL
-$16.28M-100%
Regenxbio logo
RegenxbioRGNX
$29.26M+146%

Segments

By segment

See full
Single Reportable-$35.64M-10.2%

Other financials

Income statement

See full
Revenue$5.8M+11.0%
Gross profit$5.5M+19.2%
Net income-$81.1M-115%
EPS (diluted)-$1.22-76.8%

Balance sheet

See full
Cash & equivalents$413.0M+62.8%
Total debt$62.8M-5.8%
Total equity$324.1M+8,195%
Total assets$985.1M+68.4%

Cash flow

See full
Operating cash flow-$28.6M+28.4%
CapEx$472.0K+81.5%
Free cash flow-$29.0M+27.7%

Valuation

See full
Market cap$3.15B+325%
Enterprise value$2.8B+406%
P/S168.5×+117×

Profitability

See full
Gross margin92.5%+4.6pp
Operating margin-1,071.5%-90.6pp
Net margin-1,350.7%-35.3pp
FCF margin-864.7%-194pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.2×
Current ratio10×0.0×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: uniQure’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 7:17 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087815
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Total operating expenses(51,681)(49,539)(101,144)(96,784)
Other income1,5982,5973,23010,903
Other expense(7,961)(2,185)(9,412)(4,144)
Loss from operations(52,203)(43,865)(97,923)(83,196)
Interest income5,0513,52410,2807,651
Interest expense(14,366)(15,591)(28,397)(30,700)
Foreign currency (losses) / gains, net(1,730)18,638(4,024)25,810
Other non-operating (losses), net(15,970)(12,201)

Item 1.Financial Statements

FAQ

What is uniQure's operating income?
uniQure (QURE) reported operating income of -$52.2M in Q2 2026.
How has uniQure's operating income changed year-over-year?
uniQure's operating income decreased by 19.0% year-over-year, from -$43.87M to -$52.2M.
What is the long-term trend for uniQure's operating income?
Over 3 years (2021 to 2025), uniQure's operating income has grown at a -15.8% compound annual growth rate (CAGR), from $310.62M to -$185.35M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about uniQure's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude